fda update on tirzepatide approves new obesity drug from Eli Lilly named Zepbound FDA Approves Tirzepatide, A Potential
Description
#GLP1Support #WellnessInnovation #WeightManagement

SURMOUNT-MAINTAIN is the trial I wanted: dropping the injectable dose, holding the line, and what the trial does not answer

Yes, patients can and should take tirzepatide and statin therapy (or other anticholesterol medications) concurrentlythere are no contraindications to combin...
A high-dose GLP-1 Plus Core plan designed for patients who may benefit from stronger dosing to support their weight management goals, with full provider oversight and titration support
However, this information is for educational purposes only and should not replace professional medical advice

Learn more on Everyday Health